Rockwell Medical (RMTI)

• Market cap: $49.8M
• 1 day: 1.32%
• 5 days: -6.67%
• 1 month: -15.38%
• 3 months: -25.60%
• 6 months: -62.98%
• Year to date: -30.63%
• 1 year: 6.94%
• 5 years: -93.33%
• 10 years: -98.59%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Employees: 237

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

248% more call options, than puts

Call options by funds: $776K | Put options by funds: $223K

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

4% less funds holding

Funds holding: 54 [Q3] → 52 (-2) [Q4]

5.12% less ownership

Funds ownership: 30.64% [Q3] → 25.51% (-5.12%) [Q4]

55% less capital invested

Capital invested by funds: $37.7M [Q3] → $16.8M (-$20.9M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $7 355% upside
• Avg. target: $7 355% upside
• High target: $7 355% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Raghuram Selvaraju 34% 1-year accuracy 116 / 342 met price target

355% upside $7

Buy Reiterated

23 Dec 2024